Fragile X-Associated Primary Ovarian Insufficiency
What is Fragile X-Associated Primary Ovarian Insufficiency?
Fragile X-Associated Primary Ovarian Insufficiency, or FXPOI, is a genetic condition that causes the ovaries to stop working normally before age 40. Women with this condition carry a premutation in the FMR1 gene. This gene change does not cause Fragile X syndrome, but it does increase the risk of early ovarian failure.
In FXPOI, the ovaries produce less estrogen and release eggs less regularly or not at all. This leads to irregular periods, fertility problems, and menopause that happens much earlier than expected. About 1 in 5 women who carry the FMR1 premutation will develop FXPOI. The condition can begin as early as the late teens or twenties.
FXPOI is different from natural menopause, which typically occurs around age 51. Getting diagnosed early helps women understand their fertility window and manage symptoms like hot flashes and bone loss. Blood tests can reveal the hormonal changes that signal ovarian insufficiency.
Symptoms
- Irregular periods or missed periods for several months
- Hot flashes and night sweats
- Vaginal dryness and discomfort during sex
- Difficulty getting pregnant or infertility
- Trouble sleeping or insomnia
- Mood changes, irritability, or depression
- Decreased sex drive
- Difficulty concentrating or brain fog
Some women with FXPOI have no symptoms early on. The first sign is often difficulty conceiving or changes in menstrual cycles. Others may experience menopause symptoms years before expecting them.
Concerned about Fragile X-Associated Primary Ovarian Insufficiency? Check your levels.
Screen for 1,200+ health conditions
Causes and risk factors
FXPOI is caused by a premutation in the FMR1 gene on the X chromosome. This genetic change contains 55 to 200 repeats of a specific DNA sequence. Women inherit this premutation from a parent. The premutation disrupts normal ovarian function, causing follicles to deplete faster than usual. About 20 percent of women with the FMR1 premutation develop FXPOI.
Risk factors include a family history of early menopause, having a child with Fragile X syndrome, or relatives with tremor and balance problems in older age. Autoimmune conditions and chemotherapy can also cause primary ovarian insufficiency, but these are not related to the FMR1 gene. Women under 40 with irregular periods should consider both genetic and hormonal testing.
How it's diagnosed
FXPOI is diagnosed through a combination of blood tests and genetic testing. Blood tests measure hormone levels, particularly luteinizing hormone or LH, which becomes elevated when the ovaries are not functioning properly. Follicle-stimulating hormone or FSH also rises in ovarian insufficiency. These tests are typically done on day 3 of the menstrual cycle or at any time if periods have stopped.
If blood work shows elevated LH and FSH in a woman under 40, genetic testing for the FMR1 premutation is recommended. Rite Aid's testing service includes LH measurement, which can help identify hormonal changes related to ovarian insufficiency. Early detection allows for fertility planning and treatment to manage symptoms and protect bone health.
Treatment options
- Hormone replacement therapy with estrogen and progesterone to manage symptoms and protect bone health
- Calcium and vitamin D supplements to prevent osteoporosis
- Regular weight-bearing exercise to maintain bone density
- Fertility counseling and assisted reproductive technology if pregnancy is desired
- Egg or embryo freezing before ovarian function declines further
- Vaginal moisturizers or lubricants for dryness
- Stress management techniques like yoga or meditation
- Regular follow-up with a reproductive endocrinologist or gynecologist
- Genetic counseling to understand inheritance risks for future children
Concerned about Fragile X-Associated Primary Ovarian Insufficiency? Get tested at Rite Aid.
- Simple blood draw at your nearest lab
- Results in days, not weeks
- Share results with your doctor
Frequently asked questions
FXPOI causes the ovaries to stop working before age 40 due to a genetic change. Regular menopause typically occurs around age 51 as a natural part of aging. FXPOI requires medical attention and often hormone replacement therapy, while natural menopause may or may not need treatment depending on symptoms.
Pregnancy is possible but less likely with FXPOI. Some women have intermittent ovarian function and can still ovulate occasionally. Fertility treatments like egg donation have higher success rates. If you want to have children, talk to a reproductive endocrinologist as soon as possible about your options.
Doctors diagnose FXPOI with blood tests that measure luteinizing hormone and follicle-stimulating hormone levels. If these hormones are elevated in a woman under 40, genetic testing for the FMR1 premutation is recommended. Multiple tests over several months may be needed to confirm the diagnosis.
Early signs include irregular or missed periods, difficulty getting pregnant, and hot flashes before age 40. Some women notice vaginal dryness or mood changes. Many women have no symptoms at first and only discover the condition when trying to conceive.
Yes, FXPOI is inherited through the FMR1 gene premutation on the X chromosome. Women can pass this gene change to their children. If you have FXPOI, your daughters have a 50 percent chance of inheriting the premutation and potentially developing FXPOI themselves.
Luteinizing hormone and follicle-stimulating hormone blood tests reveal ovarian insufficiency. LH levels become elevated when ovaries are not producing enough estrogen. These hormone levels are measured early in the menstrual cycle or at any time if periods have stopped.
The main treatment is hormone replacement therapy with estrogen and progesterone to manage symptoms and prevent bone loss. Calcium and vitamin D supplements help protect bones. Women who want to become pregnant may explore fertility treatments or egg donation with their doctor.
Yes, FXPOI increases the risk of osteoporosis because low estrogen levels weaken bones. Women with FXPOI lose bone density faster than women who reach menopause at a normal age. Hormone replacement therapy, calcium supplements, vitamin D, and weight-bearing exercise help protect bone health.
Lifestyle changes support overall health but cannot reverse FXPOI. Regular exercise helps maintain bone density and manage weight. A diet rich in calcium and vitamin D supports bone health. Stress management techniques may help with mood symptoms and sleep problems.
Yes, irregular periods before age 40 warrant hormone testing. Blood tests measuring LH and FSH can reveal if your ovaries are functioning normally. If results are abnormal, genetic testing for the FMR1 premutation is recommended. Early diagnosis allows for better fertility planning and symptom management.